Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

36

Revenue 2017

Xtandi

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Xtandi was produced by Astellas.

Deal Watch August 2016

Deal Watch August 2016 35! Although Pfizer pointed to the $2.2bn of Xtandi sales for advanced metastatic prostate cancer, this product has been under licence to Astellas since 2009, including a US profit share ... Headline £m. Medivation (US). Pfizer (US). Company acquisition.

Pfizer rides out Sanofi and confirms $14bn Medivation takeover

Pfizer rides out Sanofi and confirms $14bn Medivation takeover Success of cancer specialist’s drug Xtandi followed by work on other cancer drugs.  . ... There is plenty of room for further growth of Xtandi, according to analysts.

Astellas promotes John Demaree

Astellas promotes John Demaree Demaree was promoted from his position as executive director of oncology marketing, where he oversaw the launch of prostate cancer drug Xtandi (enzalutamide) and promotion of lung cancer therapy Tarceva (erlotinib).

Medivation softens on Sanofi takeover and opens its books

Medivation softens on Sanofi takeover and opens its books The main prize at present for Sanofi is the fast-growing prostate cancer drug Xtandi (enzalutamide), which made $1.9bn in sales last year, and which Medivation is attempting to move

Sanofi moves to replace Medivation board

Sanofi moves to replace Medivation board Sanofi is seeking to remove and replace Medivation's eight member board of directors in an attempt to gain control of the US firm - and its prize prostate cancer therapy, Xtandi ... Medivation's advanced castration-resistant prostate cancer blockbuster

[ Previous 5 results ] 2 3 4 5 6 7 8 9 10 11 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Health Unlimited

Health Unlimited is a global health consultancy and communications agency built by specialists with unmatched experience, perspective and expertise. For...

Latest intelligence

Webinar: Usability and UX: You’ve been asked to test...What next?
Thursday 27th June 2019 10am EDT / 3pm BST / 4pm CEST...
Event: EphMRA Annual Conference
We're sponsoring, exhibiting and presenting three papers at this year’s EphMRA Annual Conference in Warsaw, Poland....
Research Partnership and Janssen awarded runner-up in MR Excellence Awards
...

Infographics